Medical stories

Molex's biggest-ever acquisition adds Smiths Interconnect, boosting its reach in aerospace, defence and medical markets.

Elsevier launches Embase AI, a tool that halves biomedical data review time with natural language queries and transparent, up-to-date research summaries.

Paris-based kyron.bio has raised EUR 5.5m to advance glycan-engineering tech, aiming to improve safety and efficacy of antibody therapies for cancer and autoimmune diseases.

The Royal Marsden NHS Trust has launched the UK's first large-scale AI radiology platform, funded by NIHR, to advance cancer diagnosis and treatment research.

A report by Trustwave reveals that the UK healthcare sector ranks third globally for ransomware attacks, highlighting alarming cybersecurity vulnerabilities.

AI diagnostics is transforming healthcare by enhancing accuracy, speeding up disease detection, and reducing errors across lab tests, imaging, and genomics.

Altera has launched its Agilex 3 FPGAs and new development kits, aiming to enhance performance for demanding applications across various sectors.

Labour unveils a plan to deliver 40,000 extra NHS appointments weekly, focusing on health technologies and efficiency to tackle fiscal challenges.

Advances in AI spark both optimism and worry, with experts debating its impact on marketing, democracy, and human existence.

At CES 2024, OMNIVISION announced the launch of OP03050, a single-chip LCOS panel for AR/XR/MR smart glasses, enriching video conferencing and streaming with high-resolution visuals.

Global recruiter The IN Group acquires BioTalent, reinforcing its life sciences division while spotlighting AI and data research.

Everspin Technologies is set to expand their top-tier, high-density STT-MRAM product range, the EMxxLX, optimised for several electronic system sectors.

Lightware Visual Engineering reveals two new USB-C extender Active Optical Cables, promising enhanced AV flexibility.

Rapid7 has released a new report assessing the security implications of improper de-acquisition of medical infusion pumps purchased on secondary markets.

Surgical monitors market set to top $842.57m by 2032, driven by increasing geriatric population and prevalence of chronic disorders, according to FMI.

The sleep screening devices market is predicted to expand at a CAGR of 6.6% between 2023 and 2033, totalling around US$17.5 billion by 2033.